Changes in US antidepressant and antipsychotic prescription patterns in the time period following FDA actions

被引：0
|
作者：
Pamer, Carol [1 ]
Kaplan, Sigal [1 ]
Wu, Yu-Te [2 ]
Hammad, Tarek A. [1 ]
Mosholder, Andrew D. [1 ]
Rochester, George [2 ]
机构：
[1] US FDA, Off Surveillance & Epidemiol, Silver Spring, MD USA
[2] US FDA, Off Biostat, Silver Spring, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2008年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
217
引用
收藏
页码：S95 / S96
页数：2
相关论文
共 50 条
  • [1] Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions
    Pamer, Carol A.
    Hammad, Tarek A.
    Wu, Yu-te
    Kaplan, Sigal
    Rochester, George
    Governale, Laura
    Mosholder, Andrew D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (02) : 158 - 174
  • [2] Changes in US Oral Anticoagulant Drug Prescription Patterns During Period of FDA Actions
    Pinto, Cathy Anne
    Chen, Yong
    Wu, Jianmin
    Hammad, Tarek
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 59 - 59
  • [3] NEUROCOGNITIVE CHANGES FOLLOWING ANTIDEPRESSANT OR ANTIPSYCHOTIC TREATMENT IN THE SCHIZOPHRENIA PRODROME
    Bowie, Christopher R.
    Smith, C. W.
    McLaughlin, D.
    Auther, A.
    Cornblatt, B.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 302 - 302
  • [4] Cognitive changes following antidepressant or antipsychotic treatment in adolescents at clinical risk for psychosis
    Bowie, Christopher R.
    McLaughlin, Danielle
    Carrion, Ricardo E.
    Auther, Andrea M.
    Cornblatt, Barbara A.
    SCHIZOPHRENIA RESEARCH, 2012, 137 (1-3) : 110 - 117
  • [5] Changes in Topical Calcineurin Use Following Regulatory Actions in the US
    Moeny, David
    La Grenade, Lois
    Brinker, Allen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S180 - S181
  • [6] A decline in depression treatment following FDA antidepressant warnings largely explains racial/ethnic disparities in prescription fills
    Carson, Nicholas J.
    Progovac, Ana M.
    Wang, Ye
    Cook, Benjamin L.
    DEPRESSION AND ANXIETY, 2017, 34 (12) : 1147 - 1156
  • [7] Contradictory Actions on Off-Label Use of Prescription Drugs? The FDA and CMS Versus the US Justice Department
    Curtiss, Frederic R.
    Fairman, Kathleen A.
    JOURNAL OF MANAGED CARE PHARMACY, 2009, 15 (02): : 161 - 165
  • [8] Changes in Febuxostat Prescribing Patterns Following the 2019 FDA Drug Warning
    Oryaj, Khalid
    LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (05): : 1043 - 1048
  • [9] Trend and Prescription Patterns of Antipsychotic Medications (APMs) in Asia and US: A Cross-National Comparison Study
    Su, Chien-Chou
    Lai, Edward Chia-Cheng
    Man, Kenneth K. C.
    Kubota, Kiyoshi
    Kamijima, Yukari
    Kimura, Shinya
    Stang, Paul
    Schuemie, Martijn
    Ryan, Patrick
    Zhang, Yinghong
    Wong, Ian C. K.
    Setoguch-Iwata, Soko
    Yang, Yea-Huei Kao
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 666 - 667
  • [10] Genetic basis of aminoglycoside resistance following changes in aminoglycoside prescription patterns
    Kosmidis, Chris
    Giannopoulou, Maria
    Flountzi, Anastasia
    Markogiannakis, Antonis
    Goukos, Dimitris
    Petrikkos, George
    Daikos, George L.
    Tzanetou, Konstantina
    JOURNAL OF CHEMOTHERAPY, 2013, 25 (04) : 217 - 221
12345